A novel multi-analyte serum panel combining CA-125, HE4, microrna-200a, and interleukin-6 for the preclinical detection of high-grade serous ovarian carcinoma in women with pathogenic BRCA1/2 variants

Journal of Medical Biochemistry · Published 2026-01-01 · DOI 10.5937/jomb0-65630

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.5937/jomb0-65630

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles